Proliferative Diabetic Retinopathy (PDR) Completed Phase 4 Trials for Bevacizumab (DB00112)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04674254
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic RetinopathyTreatment
NCT01854593
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyTreatment
NCT01724385
Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyTreatment
NCT02096874
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular EdemaTreatment
NCT01025934
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic RetinopathyTreatment